Get the tools used by (smart)2 investors.

Return on Invested Capital for GSK plc DRC

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

GSK: GSK plc DRC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the ...

- USD
Price
USD
Fair Value
Upside
- - -
52-week range

Analysis

Benchmarks

Metric Usage: Return on Invested Capital

Hide this widget
roic
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Return on Invested Capital in the efficiency category include:

View Full List

Search for metric or datapoint

Return on Invested Capital

A capital efficiency ratio used to measure a firm's ability to create value for all its stakeholders, debt, and equity.

Definition of Return on Invested Capital

Hide this widget

Return on Invested Capital or ROIC is defined as:

Net Operating Profit After Tax
(/) Average Invested Capital
Return on Invested Capital

Return on Invested Capital for GSK is calculated as follows:

Net Operating Profit After Tax [ £5.627 B ]
(/) Average Invested Capital over Period [ £30.442 B ]
(=) Return on Invested Capital [ 18.5% ]

Where Invested Capital is calculated as follows:

(+) Average debt = (£18.018 B + £16.986 B) / 2 = £17.502 B
(+) Average Equity = (£12.795 B + £13.086 B) / 2 = £12.941 B
(=) Invested Capital [ £30.442 B ]

The tables below summarizes the trend in GSK’s return on assets over the last five years:

Fiscal Year Net Operating Profit After Tax Average Invested Capital Return on Invested Capital
2020-12-31 £5.505 B £48.413 B 11.4%
2021-12-31 £5.127 B £46.737 B 11.0%
2022-12-31 £6.663 B £38.3 B 17.4%
2023-12-31 £7.647 B £30.948 B 24.7%
2024-12-31 £5.627 B £30.442 B 18.5%

Return on Invested Capital is used to evaluate the ability of the company to create value for all its stakeholders, debt and equity. ROIC can be used to benchmark companies within an industry but it is also useful to consider its relationship to the Weighted Average Cost of Capital (WACC).

Since ROIC measures the company’s ability to generate a return on invested capital, and the WACC measures the minimum return required by the company’s capital providers (equity and debt), the difference between ROIC and WACC is referred to as Economic Profit or Excess Return.

Excess Return = Return on Invested Capital - Weighted Average Cost of Capital


Click the link below to download a spreadsheet with an example Return on Invested Capital calculation for GSK plc DRC below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-199.5%-139.5%-79.5%25.6%0100200

The chart above depicts the distribution of return on invested capital for companies operating in the Healthcare sector in the Developed economic region. Over 1,890 companies were considered in this analysis, and 1,820 had meaningful values. The average return on invested capital of companies in the sector is -29.2% with a standard deviation of 43.5%.

GSK plc DRC's Return on Invested Capital of 18.5% ranks in the 97.4% percentile for the sector. The following table provides additional summary stats:

Return on Invested Capital In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,896
Included Constituents1,820
Min-198.6%
Max23.3%
Median-17.0%
Mean-29.2%
Standard Deviation43.5%

You can find companies with similar return on invested capital using this stock screener.

All rights reserved. Terms Of Use